← back to search

Nicolas Stransky

Massachusetts Institute of Technology · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Biology, Cancer, Computational biology, Genetics, Genome, and Mutation.
h-index
citations
26,121
works
17
NIH funding
primary concept
email

Recent publications

Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma
Nature Communications 2023cited by 25position: middledoi
Molecular characterization of colorectal cancer related peritoneal metastatic disease
Nature Communications 2022cited by 122position: middledoi
Next-generation characterization of the Cancer Cell Line Encyclopedia
Nature 2019cited by 3,669position: middledoi
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods
Genome biology 2019cited by 685position: middledoi
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma
Cancer Discovery 2019cited by 246position: middledoi
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Nature 2018cited by 111position: middledoi
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Cell Reports 2017cited by 609position: middledoi
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Cell Reports 2017cited by 247position: middledoi
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies
Scientific Data 2014cited by 413position: middledoi
Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes
Nature Communications 2014cited by 169position: middledoi
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Nature 2013cited by 5,691position: middledoi
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Nature 2012cited by 8,455position: middledoi
A Landscape of Driver Mutations in Melanoma
Cell 2012cited by 2,610position: middledoi
Sequence analysis of mutations and translocations across breast cancer subtypes
Nature 2012cited by 1,199position: middledoi
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Proceedings of the National Academy of Sciences 2012cited by 979position: middledoi
Melanoma genome sequencing reveals frequent PREX2 mutations
Nature 2012cited by 766position: middledoi
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Nature Genetics 2012cited by 125position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2014–2014)Ethan Cerami · Dana-Farber/Harvard Cancer Center1 papers (2014–2014)Lisa Kann · Circulomics (United States)1 papers (2014–2014)Mark Sausen · Human Genome Sciences (United States)1 papers (2014–2014)Nathalie Pochet · Albert Einstein College of Medicine1 papers (2019–2019)Bo Li · Yuhuangding Hospital1 papers (2019–2019)Manish Shukla · Pennsylvania State University1 papers (2014–2014)Siân Jones · Human Genome Sciences (United States)1 papers (2014–2014)Aviv Regev · Moscow Institute of Thermal Technology1 papers (2019–2019)Victor E. Velculescu · Sidney Kimmel Cancer Center1 papers (2014–2014) · 1 papers (2014–2014)Samuel V. Angiuoli · Weill Cornell Medicine1 papers (2014–2014)Brian J. Haas · Broad Institute1 papers (2019–2019)Alexander Dobin · New York Proton Center1 papers (2019–2019)Christoph Lengauer · Blueprint Medicines (United States)1 papers (2014–2014) · 1 papers (2014–2014)Laura D. Wood · Wellcome Sanger Institute1 papers (2014–2014)Luis A. Díaz · Secretaria de Salud1 papers (2014–2014) · 1 papers (2014–2014)